MARKET

ABBV

ABBV

AbbVie
NYSE

Real-time Quotes | Nasdaq Last Sale

115.75
-0.33
-0.28%
After Hours: 115.84 +0.09 +0.08% 17:54 05/07 EDT
OPEN
116.38
PREV CLOSE
116.08
HIGH
116.93
LOW
114.96
VOLUME
6.81M
TURNOVER
--
52 WEEK HIGH
116.93
52 WEEK LOW
79.11
MARKET CAP
204.28B
P/E (TTM)
42.71
1D
5D
1M
3M
1Y
5Y
Global HIV Drugs Market Report 2021: Long-term Forecast to 2025 & 2030 - ResearchAndMarkets.com
The "HIV Drugs Global Market Report 2021: COVID-19 Implications and Growth to 2030" report has been added to ResearchAndMarkets.com's offering.
BusinessWire · 4h ago
Ironwood's (IRWD) Q1 Earnings Beat, 2021 Guidance Muted
Ironwood (IRWD) witnesses strong demand for Linzess in the first quarter. However, outlook for 2021 misses market expectations. Stock down.
Zacks · 6h ago
Stocks That Hit 52-Week Highs On Friday
    On Friday morning, 417 companies achieved new highs for the year.
Benzinga · 7h ago
AbbVie Stock Is Tackling Its New Buy Point Is It A Buy Right Now?
Investor's Business Daily · 9h ago
Orphan drugs Market Segments, Trends, Industry Growth, Landscape and Demand by Forecast to 2027
May 06, 2021 (Heraldkeepers) -- Orphan Drugs Market Research Report: Information by Drug Type (Biologics & Non-Biologics), Sale (Generics & Prescribed),...
Heraldkeepers · 1d ago
Orphan diseases Market Analysis Revealing Key Drivers, Growth Trends and Competitive Assessment through 2027
May 06, 2021 (Heraldkeepers) -- Market Scenario: Global orphan diseases market also known as rare disease is growing rapidly. It affects a very small...
Heraldkeepers · 1d ago
Anesthesia Drugs Market Industry Analysis, Key Player profile, Size, Share, Growth and Trends 2027
May 06, 2021 (Heraldkeepers) -- Global Anesthesia Drugs Market information, by type of anesthesia (General Anesthesia, Regional Anesthesia, Local Anesthesia,...
Heraldkeepers · 1d ago
BRCA Mutation-Positive Ovarian Cancer Market 2020-2030 Global Analysis, Size, Share, Incredible Growth, Detailed Industry Analysis and Business Prospects | FMI
May 06, 2021 (MARKITWIRED via COMTEX) -- A patient with high grade serious ovarian cancer who carry germline mutations in BRCA 1/2 genes is known as BRCA...
Markitwired · 1d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of ABBV. Analyze the recent business situations of AbbVie through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 24 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average ABBV stock price target is 123.78 with a high estimate of 144.00 and a low estimate of 105.00.
EPS
Institutional Holdings
Institutions: 3.23K
Institutional Holdings: 1.27B
% Owned: 71.75%
Shares Outstanding: 1.76B
TypeInstitutionsShares
Increased
1.08K
48.61M
New
322
11.06M
Decreased
861
72.08M
Sold Out
86
2.37M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
+0.86%
Pharmaceuticals & Medical Research
+1.04%
Key Executives
Chairman/Chief Executive Officer/Director
Richard Gonzalez
President/Vice Chairman - Management
Michael Severino
Vice Chairman - Management
Laura Schumacher
Chief Financial Officer/Executive Vice President
Robert Michael
Chief Human Resource Officer/Executive Vice President
Timothy Richmond
Executive Vice President
Henry Gosebruch
Executive Vice President
Azita Saleki - Gerhardt
Senior Vice President
Thomas Hudson
Executive Vice President
Azita Saleki-Gerhardt
Senior Vice President
Elaine Sorg
Senior Vice President
Jeffrey Stewart
Senior Vice President
Carrie Strom
Vice President/Controller
Brian Durkin
Lead Director/Independent Director
Glenn Tilton
Independent Director
Robert Alpern
Independent Director
Roxanne Austin
Independent Director
William Burnside
Independent Director
Thomas Freyman
Independent Director
Brett Hart
Independent Director
Edward Liddy
Independent Director
Melody Meyer
Independent Director
Edward Rapp
Independent Director
Rebecca Roberts
Independent Director
Frederick Waddell
Declaration Date
Dividend Per Share
Ex-Div Date
02/18/2021
Dividend USD 1.3
04/14/2021
10/30/2020
Dividend USD 1.3
01/14/2021
09/11/2020
Dividend USD 1.18
10/14/2020
06/17/2020
Dividend USD 1.18
07/14/2020
02/20/2020
Dividend USD 1.18
04/14/2020
11/01/2019
Dividend USD 1.18
01/14/2020
09/06/2019
Dividend USD 1.07
10/11/2019
06/20/2019
Dividend USD 1.07
07/12/2019
02/21/2019
Dividend USD 1.07
04/12/2019
11/02/2018
Dividend USD 1.07
01/14/2019
09/07/2018
Dividend USD 0.96
10/12/2018
06/14/2018
Dividend USD 0.96
07/12/2018
02/15/2018
Dividend USD 0.96
04/12/2018
10/26/2017
Dividend USD 0.71
01/11/2018
09/08/2017
Dividend USD 0.64
10/12/2017
06/23/2017
Dividend USD 0.64
07/12/2017
02/17/2017
Dividend USD 0.64
04/11/2017
10/31/2016
Dividend USD 0.64
01/11/2017
09/09/2016
Dividend USD 0.57
10/12/2016
06/16/2016
Dividend USD 0.57
07/13/2016
02/18/2016
Dividend USD 0.57
04/13/2016
10/30/2015
Dividend USD 0.57
01/13/2016
09/11/2015
Dividend USD 0.51
10/13/2015
06/19/2015
Dividend USD 0.51
07/13/2015
02/19/2015
Dividend USD 0.51
04/13/2015
10/21/2014
Dividend USD 0.49
01/13/2015
09/19/2014
Dividend USD 0.42
10/10/2014
06/19/2014
Dividend USD 0.42
07/11/2014
02/20/2014
Dividend USD 0.42
04/11/2014
12/12/2013
Dividend USD 0.4
01/13/2014
09/19/2013
Dividend USD 0.4
10/10/2013
06/20/2013
Dividend USD 0.4
07/11/2013
About ABBV
AbbVie Inc. (AbbVie) is a research-based biopharmaceutical company. The Company is engaged in the discovery, development, manufacture and sale of a range of pharmaceutical products. Its products are focused on treating conditions, such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease and multiple sclerosis; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis, and other serious health conditions. It offers products in various categories, including HUMIRA (adalimumab), Oncology products, Virology Products, Additional Virology products, Metabolics/Hormones products, Endocrinology products and other products, which include Duopa and Duodopa (carbidopa and levodopa), Anesthesia products and ZINBRYTA (daclizumab).

Webull offers kinds of AbbVie Inc stock information, including NYSE:ABBV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ABBV stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ABBV stock methods without spending real money on the virtual paper trading platform.